CLINICAL TRIALS PROFILE FOR LIXIVAPTAN
✉ Email this page to a colleague
Clinical Trials for Lixivaptan
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00578695 ↗ | THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation | Completed | Biogen | Phase 3 | The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure. |
NCT00578695 ↗ | THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation | Completed | Cardiokine Biopharma, LLC | Phase 3 | The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure. |
NCT00578695 ↗ | THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation | Completed | CardioKine Inc. | Phase 3 | The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Lixivaptan
Condition Name
Clinical Trial Locations for Lixivaptan
Trials by Country
Clinical Trial Progress for Lixivaptan
Clinical Trial Phase
Clinical Trial Sponsors for Lixivaptan
Sponsor Name